Ciliary dysfunction impairs beta-cell insulin secretion and promotes development of type 2 diabetes in rodents

被引:89
|
作者
Gerdes, Jantje M. [1 ,2 ]
Christou-Savina, Sonia [3 ]
Xiong, Yan [1 ]
Moede, Tilo [1 ]
Moruzzi, Noah [1 ,2 ]
Karlsson-Edlund, Patrick [1 ]
Leibiger, Barbara [1 ]
Leibiger, Ingo B. [1 ]
Ostenson, Claes-Goran [4 ]
Beales, Philip L. [3 ]
Berggren, Per-Olof [1 ]
机构
[1] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17176 Stockholm, Sweden
[2] Helmholtz Ctr Munich, Inst Diabet & Regenerat Res, D-85748 Garching, Germany
[3] UCL Inst Child Hlth, Mol Med Unit, London WCN1N 1EH, England
[4] Karolinska Univ Hosp, Karolinska Inst, Endocrine & Diabet Unit, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden
来源
NATURE COMMUNICATIONS | 2014年 / 5卷
基金
瑞典研究理事会;
关键词
PRIMARY-CILIUM; GLUCOSE-METABOLISM; GENE-EXPRESSION; MOUSE MODEL; PROTEIN; RECEPTOR; PHOSPHORYLATION; ISLETS; MICE; BBS4;
D O I
10.1038/ncomms6308
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Type 2 diabetes mellitus is affecting more than 382 million people worldwide. Although much progress has been made, a comprehensive understanding of the underlying disease mechanism is still lacking. Here we report a role for the beta-cell primary cilium in type 2 diabetes susceptibility. We find impaired glucose handling in young Bbs4(-/-) mice before the onset of obesity. Basal body/ciliary perturbation in murine pancreatic islets leads to impaired first phase insulin release ex and in vivo. Insulin receptor is recruited to the cilium of stimulated beta-cells and ciliary/basal body integrity is required for activation of downstream targets of insulin signalling. We also observe a reduction in the number of ciliated beta-cells along with misregulated ciliary/basal body gene expression in pancreatic islets in a diabetic rat model. We suggest that ciliary function is implicated in insulin secretion and insulin signalling in the beta-cell and that ciliary dysfunction could contribute to type 2 diabetes susceptibility.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
    van Raalte, Daniel H.
    Verchere, C. Bruce
    DIABETES OBESITY & METABOLISM, 2017, 19 (09) : 1205 - 1213
  • [2] Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus
    Gastaldelli, Amalia
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 : S60 - S65
  • [3] The GK rat beta-cell: A prototype for the diseased human beta-cell in type 2 diabetes?
    Portha, B.
    Lacraz, G.
    Kergoat, M.
    Homo-Delarche, F.
    Giroix, M. -H.
    Bailbe, D.
    Gangnerau, M. -N.
    Dolz, M.
    Tourrel-Cuzin, C.
    Movassat, J.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 297 (1-2) : 73 - 85
  • [4] Research progress on the mechanism of beta-cell apoptosis in type 2 diabetes mellitus
    You, SuFang
    Zheng, JingYi
    Chen, YuPing
    Huang, HuiBin
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [5] Concise Review: Beta-Cell Dedifferentiation in Type 2 Diabetes
    Efrat, Shimon
    STEM CELLS, 2019, 37 (10) : 1267 - 1272
  • [6] Beta-cell specific Insr deletion promotes insulin hypersecretion and improves glucose tolerance prior to global insulin resistance
    Skovso, Sos
    Panzhinskiy, Evgeniy
    Kolic, Jelena
    Cen, Haoning Howard
    Dionne, Derek A.
    Dai, Xiao-Qing
    Sharma, Rohit B.
    Elghazi, Lynda
    Ellis, Cara E.
    Faulkner, Katharine
    Marcil, Stephanie A. M.
    Overby, Peter
    Noursadeghi, Nilou
    Hutchinson, Daria
    Hu, Xiaoke
    Li, Hong
    Modi, Honey
    Wildi, Jennifer S.
    Botezelli, J. Diego
    Noh, Hye Lim
    Suk, Sujin
    Gablaski, Brian
    Bautista, Austin
    Kim, Ryekjang
    Cras-Meneur, Corentin
    Flibotte, Stephane
    Sinha, Sunita
    Luciani, Dan S.
    Nislow, Corey
    Rideout, Elizabeth J.
    Cytrynbaum, Eric N.
    Kim, Jason K.
    Bernal-Mizrachi, Ernesto
    Alonso, Laura C.
    MacDonald, Patrick E.
    Johnson, James D.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [7] A beta cell subset with enhanced insulin secretion and glucose metabolism is reduced in type 2 diabetes
    Rubio-Navarro, Alfonso
    Gomez-Banoy, Nicolas
    Stoll, Lisa
    Dundar, Friederike
    Mawla, Alex M.
    Ma, Lunkun
    Cortada, Eric
    Zumbo, Paul
    Li, Ang
    Reiterer, Moritz
    Montoya-Oviedo, Nathalia
    Homan, Edwin A.
    Imai, Norihiro
    Gilani, Ankit
    Liu, Chengyang
    Naji, Ali
    Yang, Boris
    Chong, Angie Chi Nok
    Cohen, David E.
    Chen, Shuibing
    Cao, Jingli
    Pitt, Geoffrey S.
    Huising, Mark O.
    Betel, Doron
    Lo, James C. C.
    NATURE CELL BIOLOGY, 2023, 25 (04) : 565 - +
  • [8] Pancreatic beta-cell Glucose Toxicity in Type 2 Diabetes Mellitus
    Kaneto, Hideaki
    CURRENT DIABETES REVIEWS, 2015, 11 (01) : 2 - 6
  • [9] Beta-cell Management in Type 2 Diabetes: Beneficial Role of Nutraceuticals
    Singh, Himadri
    Venkatesan, Vijayalakshmi
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2016, 16 (02) : 89 - 98
  • [10] Beta-Cell Specific Deletion of Dicer1 Leads to Defective Insulin Secretion and Diabetes Mellitus
    Kalis, Martins
    Bolmeson, Caroline
    Esguerra, Jonathan L. S.
    Gupta, Shashank
    Edlund, Anna
    Tormo-Badia, Neivis
    Speidel, Dina
    Holmberg, Dan
    Mayans, Sofia
    Khoo, Nelson K. S.
    Wendt, Anna
    Eliasson, Lena
    Cilio, Corrado M.
    PLOS ONE, 2011, 6 (12):